Citation: H. Reuveni et al., A cost-effectiveness analysis of alternative at-home or in-laboratory technologies for the diagnosis of obstructive sleep apnea syndrome, MED DECIS M, 21(6), 2001, pp. 451-458
Authors:
Asaf, T
Reuveni, H
Yermiahu, T
Leiberman, A
Gurman, G
Porat, A
Schlaeffer, P
Shifra, S
Kapelushnik, J
Citation: T. Asaf et al., The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy, INT J PED O, 61(3), 2001, pp. 217-222
Authors:
Reuveni, H
Aviram, EE
Elhayani, A
Lifshitz, M
Peled, R
Galai, N
Sherf, M
Paran, E
Citation: H. Reuveni et al., The prescription pattern of oral nitrates in coronary artery disease - Appropriateness and cost considerations, EUR J CL PH, 57(8), 2001, pp. 595-597
Authors:
Reuveni, H
Geiger, T
Geiger, B
Levitzki, A
Citation: H. Reuveni et al., Reversal of the Ras-induced transformed phenotype by HR12, a novel Ras farnesylation inhibitor, is mediated by the Mek/Erk pathway, J CELL BIOL, 151(6), 2000, pp. 1179-1192
Authors:
Poradosu, E
Gazit, A
Reuveni, H
Levitzki, A
Citation: E. Poradosu et al., alpha-Cyanocinnamide derivatives: A new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylation, BIO MED CH, 7(8), 1999, pp. 1727-1736